October 17, 2014

DrugDev and AstraZeneca to Host Educational Case Study Webinar, “S.O.S. – Best Practices for Finding, Engaging and Activating Investigators on a Rescue Study,” October 21, 2014

AUDUBON, Pa. & LONDON- DrugDev will join AstraZeneca to host an educational and complimentary webinar designed to help sponsors find, engage and activate the best sites for a clinical rescue study. The webinar case study will be held on October 21 at 11:30am EDT.

Finding qualified investigator sites who can deliver patients is always a challenge – especially when the study has started and teams find themselves behind their enrollment projections. As the project goes into “rescue mode,” study teams must not only find additional sites, but also activate and engage them quickly.

The webinar will detail results of a case study in which a sponsor found sites in a highly competitive therapeutic area with a number of competing ongoing studies, and successfully rescued their study. Presenters will also discuss how combining a technology-enabled solution with the knowledge of industry experts provides the best solution for identifying, engaging and effectively activating the appropriate sites.

Date: Tuesday, October 21, 2014
Time: 11:30am EDT (NA) / 4:30pm BST (UK) / 5:30pm CEST (EU-Central)
Duration: 60 minutes

Attendees will be able to:

  • Understand how to use technology to pre-qualify sites ahead of a site visit, and minimize burdens on the site
  • Describe the benefits of sharing as much information as possible with investigators during site identification
  • Discover industry best practices that can both automate and expedite several key steps in the site activation process
  • Learn how to harness the power of your existing site data and documents to shorten activation in a rescue situation

About the Speakers

William Turnbull, Local Study Leader, AstraZeneca – As a CRA for AstraZeneca, Mr. Turnbull is involved with trials from study concept through database lock and study close-out activities. His primary responsibility is to monitor the progress of the clinical sites participating in studies to assure protocol is followed and the data is reported accurately and in a timely fashion.

Kirsty Kwiatkowski, Director, Feasibility and Site Identification, DrugDev – Ms. Kwiatkowski oversees the DrugDev Investigator Network and all Site Services projects.

Jim DiCesare, Vice President, Contracting & Regulatory Services, DrugDev – Mr. DiCesare leads a highly skilled and experienced team of individuals who are responsible for delivering study startup services to clinical trial sponsors and CROs.

DrugDev is a leading provider of technology-driven solutions that help investigators, sponsors and CROs do more clinical trials together. Learn more at

About DrugDev

DrugDev simplifies life at the clinical trial site through technology and enables sponsors, CROs and investigators to do more trials together. DrugDev creates and drives standards which promote collaboration, improve quality, shorten timelines and reduce cost. Our solutions include the largest global network of active investigators; the industry’s leading grant payment and site contracting system in CFS Clinical; and, the award-winning TrialNetworks platform of clinical operations apps. DrugDev provides Hosted Data Solutions for clinical trials including hosting the Investigator Databank for Novartis, Janssen, Merck, Lilly and Pfizer. Learn more at